This week Mad in America examines studies related to adverse events associated with antipsychotics and antidepressants, ...

Bayer presents positive data on asundexian, which shows superior efficacy with no added bleeding risk, boosting hopes for regulatory approval.

Byfield is one of over 100,000 people waiting for a life-saving organ transplant in the country.

Kite, a Gilead Company , today announced the U.S. Food and Drug Administration (FDA) approved an update to the Yescarta® (axicabtagene ciloleucel) prescribing information removing the previous ...

Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...

American Stroke Association International Stroke Conference 2026 annual awards go to 11 stroke researchers for science, brain health contributions.

Eleven top scientists in stroke and brain health will be recognized for their individual exceptional professional ...

BACKGROUND: The disruption of the blood–brain barrier (BBB) is a central pathogenic event in many central nervous system disorders. However, the mechanisms regulating BBB function remain incompletely ...

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...